2025 Conference Archive: Speakers
Peter Mol
Professor of drug regulatory science at UMCG & Committee member CHMP for the Dutch Medicines Evaluation Board.
Steve Williamson
Associate Director of Managed Access
The National Institute for Health and Care Excellence (NICE)
Pamela Dobay
Director, R&D | Quantitative Sciences and Development Operations
Biogen
Sascha van Boemmel-Wegmann
Senior Manager Scientific Engagement RWE
Flatiron Health
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani
Associate Professor of Medical Oncology & Committee Member CieBAG
LUMC & National Payer´s Evaluation Committee CieBAG
Tarang Sharma
Technical Officer Novel Medicines Platform & HTA
World Health Organization
Finlay MacDougall
Head Real World Networks & Partnerships, EMEA
IQVIA
Leo Russo
Vice President & Head of Medical RWE & Epidemiology
Pfizer & GetReal Board Member
Carlos Martín Saborido
Director of the Health Technology Assessment Agency
Instituto de Salud Carlos III
Ashwin Kumar Rai
Director of Data Science & Advanced Analytics
Thermo Fisher Scientific
Anke van Engen
Global Category Leader, Health Economics, Health Technology Assessment, Value & Access.
IQVIA
Iain Armstrong
Chair of the Pulmonary Hypertension Association & Consultant Nurse
PHA UK & Sheffield Pulmonary Vascular Disease Unit
Mira Zuidgeest
Associate Professor
University Medical Center Utrecht (UMCU) & GetReal Board Chair
Christine Leopold
Assistant Professor of Drug Regulatory Science
Utrecht University & GetReal Board Member
Charlie Nicholls
Head, Global HEOR (HEVA) – General Medicines
Sanofi & GetReal Board Member
Melissa Estevez
Director of Research Sciences
Flatiron Health
Susan Oliveria
Vice President, Global Head of Epidemiology and Scientific Affairs
Thermo Fisher Scientific & GetReal Board Member
Bettina Ryll
Founder
Melanoma Patient Network Europe
Carole Longson
Senior Adviser, Life Science Policy, HTA and Market Access
Independent Adviser
Neil Grubert
Global Market Access Consultant, Trainer, and Writer
Independent Consultant
Tim Williams
Head of Interventional Research
Clinical Practice Research Datalink (CPRD)
Mariam Bibi
Managing Director
The GetReal Institute
Stephen Duffield
Associate Director – Real-world evidence methods
NICE
Katrien Oude Rengerink
Methodology Assessor & Coordinator
The Medicines Evaluation Board (CBG-MEB)
Martin Russek
Doctoral Researcher & Scientist
BfArM
Daniala Weir
Assistant Professor of Real World Evidence
Utrecht University
Catherine Cohet
Pharmacoepidemiology / RWE Senior Specialist Data Analytics & Methods Task Force
European Medicines Agency (EMA)
Lourens Bloem
Assistant Professor Clinical Therapeutics
Utrecht University
Melinda Hanisch
Principal Scientist, Science & Regulatory Policy
MSD
Patrice Verpillat
Head of Real World Evidence
European Medicines Agency (EMA)
Calum Yacoubian
Director Healthcare Strategy, Applied AI Science
IQVIA
Frauke Naumann-Winter
Clinical Assessor Oncology
BfArM
Jan-Willem Versteeg
PHD student – Health technology assessment (HTA)
Utrecht University
Ian Bonzani
Head of Sales Engineering Team of Patient Insights, Experience & Registry Solutions Practice
IQVIA
Kevin Marsh
VP, Global Head Patient Centred Research
Thermo Fisher Scientific